ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
US top court denies Indivior’s request on suboxone, Dr Reddy’s gains Hyderabad
February 21, 2019Indivior is in legal battle against the launch of copycat version of its opioid addiction treatment by competitors including Dr Reddy’s Laboratories in the US market -
Indivior shares soar as US judge rules against Dr Reddy
July 17, 2018Shares in the London listed addiction specialist Indivior surged in price today, as the Indian pharmaceutical company Dr Reddy’s Laboratories was blocked from selling generic versions of Indivior’s bestselling opioid addiction treatment, Suboxone Film, in -
Dr Reddy's just-approved opioid dependence generic blocked over US patent dispute
June 22, 2018Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) secured FDA approval for the treatment of opioid dependence, -
Dr Reddy’s Srikakulam unit clears US FDA audit
September 29, 2017The US Food and Drug Administration (US FDA) has cleared pharma major Dr Reddy’s Laboratories Ltd’s formulation Srikakulam Plant (SEZ) Unit I in Andhra Pradesh from its recent audit. -
South Korea’s Mezzion Pharma files suit against Dr Reddy’s in US
February 07, 2017Hyderabad-based Dr Reddy’s has, however, said it is yet to receive any ‘legal papers’.
Pharma Sources Insight January 2025
